Literature DB >> 27139478

Geographic Differences in the Contribution of ubiA Mutations to High-Level Ethambutol Resistance in Mycobacterium tuberculosis.

Subramanya Lingaraju1, Leen Rigouts2, Aditi Gupta1, Jongseok Lee3, Alaine Nyaruhirira Umubyeyi4, Amy L Davidow5, Susan German5, EunJin Cho3, Ji-Im Lee3, Sang-Nae Cho6, Cheon Tae Kim7, David Alland1, Hassan Safi8.   

Abstract

Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in Mycobacterium tuberculosis We evaluated the prevalence of ubiA and embB (Rv3795) mutations in EMB-resistant strains originating from Africa and South Korea. No differences in embB mutation frequencies were observed between strains from both origins. However, ubiA mutations were present in 45.5% ± 6.5% of the African EMB-resistant isolates but in only 9.5% ± 1.5% of the South Korean EMB-resistant isolates. The ubiA mutations associated with EMB resistance were localized to regions encoding the transmembrane domains of the protein, whereas the embB mutations were localized to regions encoding the extramembrane domains. Larger studies are needed to investigate the causes of increased ubiA mutations as a pathway to high-level EMB resistance in African countries, such as extended EMB usage during tuberculosis treatment.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27139478      PMCID: PMC4914663          DOI: 10.1128/AAC.03002-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol.

Authors:  A Telenti; W J Philipp; S Sreevatsan; C Bernasconi; K E Stockbauer; B Wieles; J M Musser; W R Jacobs
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

2.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

3.  Mutations in the embC-embA intergenic region contribute to Mycobacterium tuberculosis resistance to ethambutol.

Authors:  Zhenling Cui; Yuanyuan Li; Song Cheng; Hua Yang; Junmei Lu; Zhongyi Hu; Baoxue Ge
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

4.  Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testing.

Authors:  Soumitesh Chakravorty; Jong Seok Lee; Eun Jin Cho; Sandy S Roh; Laura E Smith; Jiim Lee; Cheon Tae Kim; Laura E Via; Sang-Nae Cho; Clifton E Barry; David Alland
Journal:  J Clin Microbiol       Date:  2014-10-22       Impact factor: 5.948

5.  The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services.

Authors:  V Vincent; L Rigouts; E Nduwamahoro; B Holmes; J Cunningham; M Guillerm; C-M Nathanson; F Moussy; B De Jong; F Portaels; A Ramsay
Journal:  Int J Tuberc Lung Dis       Date:  2012-01       Impact factor: 2.373

6.  Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set.

Authors:  Ingrid Filliol; Alifiya S Motiwala; Magali Cavatore; Weihong Qi; Manzour Hernando Hazbón; Miriam Bobadilla del Valle; Janet Fyfe; Lourdes García-García; Nalin Rastogi; Christophe Sola; Thierry Zozio; Marta Inírida Guerrero; Clara Inés León; Jonathan Crabtree; Sam Angiuoli; Kathleen D Eisenach; Riza Durmaz; Moses L Joloba; Adrian Rendón; José Sifuentes-Osornio; Alfredo Ponce de León; M Donald Cave; Robert Fleischmann; Thomas S Whittam; David Alland
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

7.  Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

Authors:  Angela M Starks; Aysel Gumusboga; Bonnie B Plikaytis; Thomas M Shinnick; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

8.  Variable host-pathogen compatibility in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Kathryn DeRiemer; Tran Van; Midori Kato-Maeda; Bouke C de Jong; Sujatha Narayanan; Mark Nicol; Stefan Niemann; Kristin Kremer; M Cristina Gutierrez; Markus Hilty; Philip C Hopewell; Peter M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

9.  Identification of amino acids and domains required for catalytic activity of DPPR synthase, a cell wall biosynthetic enzyme of Mycobacterium tuberculosis.

Authors:  Hairong Huang; Stefan Berg; John S Spencer; Danny Vereecke; Wim D'Haeze; Marcelle Holsters; Michael R McNeil
Journal:  Microbiology       Date:  2008-03       Impact factor: 2.777

Review 10.  Genomic insights into tuberculosis.

Authors:  James E Galagan
Journal:  Nat Rev Genet       Date:  2014-03-25       Impact factor: 53.242

View more
  3 in total

Review 1.  Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.

Authors:  N P Mnyambwa; D-J Kim; E S Ngadaya; R Kazwala; P Petrucka; S G Mfinanga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-07       Impact factor: 3.267

2.  Rapidly Correcting Frameshift Mutations in the Mycobacterium tuberculosis orn Gene Produce Reversible Ethambutol Resistance and Small-Colony-Variant Morphology.

Authors:  Hassan Safi; Subramanya Lingaraju; Shuyi Ma; Seema Husain; Mainul Hoque; Patricia Soteropoulos; Tige Rustad; David R Sherman; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

Review 3.  New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.

Authors:  Mohammad J Nasiri; Mehri Haeili; Mona Ghazi; Hossein Goudarzi; Ali Pormohammad; Abbas A Imani Fooladi; Mohammad M Feizabadi
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.